3
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Radiosensitization of Hypoxic Cells by a Nitrofuran; Dose-modifying and Shoulder Effects

Pages 237-250 | Received 10 Dec 1976, Accepted 07 Jan 1977, Published online: 03 Jul 2009
 

Summary

The radiosensitizer nifurpipone dihydrochloride (5-nitro-2-furaldehyde N-methyl piperazino acetyl hydrazone dihydrochloride) sensitizes hypoxic V79 mammalian cells by at least two mechanisms. Sensitization is by a reduction of ñ in addition to an increase in slope. Both these effects are absent under oxygenated conditions. When hypoxic V79 cells are irradiated in the presence of nifurpipone dihydrochloride combined with Ro-07-0582, sensitization greater than that due to air alone is observed; this effect is due to a reduction in ñ and an increased slope. Again this effect is absent under oxygenated conditions.

Rapid-mix studies using Serratia marcescens show that full sensitization occurs with a pre-irradiation contact time of 4 msec; this contrasts with data for V79 cells where a pre-irradiation contact time of 40 msec is insufficient for any sensitization to occur.

This sensitizer also exerts a differential toxic effect, being more toxic to hypoxic cells than to oxygenated ones.

It is concluded from these results that nifurpipone dihydrochloride sensitizes by at least two mechanisms, one of which resembles that of the electron-affinic type.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.